Sabby Management »

CanFite Biopharma shares owned by Sabby Management

Quarter-by-quarter ownership of CanFite Biopharma (CANF) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in CanFite Biopharma

Tip: Access up to 7 years of quarterly data

All positions including CanFite Biopharma held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CanFite Biopharma by Sabby Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $132k 43k 3.10

More positions owned by Sabby Management

Spdr S&p 500 Etf Etf Put Option
Ishares Tr Etf Put Option
Spdr S&p 500 Etf Etf (SPY)
Gevo Put Option
Abivax Sa Ads Call Option
Alphaton Capital Corp SHS (ALP)
Briacell Therapeutics Corp *W (BCTXL)
Senestech (SNES)
Big Tree Cloud Hldgs Cl A (DSY)
Kempharm Put Option
Briacell Therapeutics Corp (BCTX)
Sidus Space Put Option
Token Cat Ads (TC)
Pop Culture Group SHS (CPOP)
Moleculin Biotech (MBRX)

View all positions for Sabby Management

Top funds holding CanFite Biopharma

Sabby Management
Citadel Advisors
Rhumbline Advisers
Hrt Financial
Virtu Financial
Citigroup
UBS Group
Advisor Group Holdings
Fifth Third Bancorp
Wells Fargo & Company
Activest Wealth Management
Efficient Wealth Management
Morgan Stanley
TD Waterhouse Canada

View all funds holding CanFite Biopharma